Details of the Drug

General Information of Drug (ID: DM31M4V)

• Drug Name: Autologous endothelial progenitor cell therapy
• Synonyms: Autologous endothelial progenitor cell therapy (ischemia); Autologous endothelial progenitor cell therapy (ischemia), IBRI; Autologous stem cell therapy (critical limb ischemia), IBRI; Autologous CD34+ cells (peripheral vascular disease), IBRI

Indication

Disease Entry	ICD 11	Status	REF
Ischemic heart disease	BA40-BA6Z	Phase 2/3	[1]

• Cross-matching ID: TTD ID: D0P1SA

References

• [1] MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases. Curr Opin Mol Ther. 2008 Dec;10(6):611-21.